Test Price
2,800 AED✅ Home Collection Available
COL2A1 Gene Achondrogenesis Type 2 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين COL2A1 للكشف عن تكون العظم الناقص من النوع الثاني في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
🔬 99.9% Diagnostic Sensitivity via ISO 15189 & ISO 9001:2015 Accredited Processing
🚑 Premium Home Collection: Hospital-grade, cold-chain certified phlebotomy service (8 AM – 11 PM daily).
🧑⚕️ Post-Test Clinical Guidance: Telephonic result interpretation by DHA-licensed genetic counsellors.
📋 Direct Insurance Billing: WhatsApp verification at +971 54 548 8731.
الملخص التنفيذي: يقدم اختبار الجين COL2A1 للكشف عن تكون العظم الناقص من النوع الثاني باستخدام تقنية التسلسل الجيني من الجيل التالي (NGS) في دولة الإمارات، وهو معتمد بالكامل من هيئة الصحة بدبي (DHA) ويتبع إرشادات 2026. يضمن المختبر المركزي الحاصل على شهادة الأيزو 9001:2015 دقة تشخيصية بنسبة 99.9% مع خدمة سحب عينات منزلية محترفة وتفسير سريري بعد الفحص، مما يوفر للمرضى والعائلات أعلى مستويات الرعاية والامتثال القانوني.
Test Overview & Methodology Comparison
The COL2A1 gene NGS test screens for pathogenic variants responsible for Achondrogenesis Type 2 (also known as Langer-Saldino type), a severe autosomal dominant skeletal dysplasia that primarily affects cartilage and bone development. This test utilizes next-generation sequencing of exonic and splice-site regions, ensuring comprehensive variant detection for clinical diagnosis, carrier screening, and family planning. يُستخدم هذا الفحص الجيني لتأكيد التشخيص السريري واتخاذ القرارات الطبية المستنيرة.
| Feature | Our Test (Health-Tech Genomics Lab) | Closest Alternative (Standard Single-Gene Sanger) |
|---|---|---|
| Methodology | NGS (Next-Generation Sequencing) with full exon coverage, CNV analysis & maternal cell contamination check | Sanger sequencing limited to specific known mutations |
| Diagnostic Yield | >99% for coding variants, including deep intronic splice variants | ~85% if only common hotspots are tested |
| Turnaround Time | 3–4 weeks (rush processing available) | 4–6 weeks |
| Sample Types | Whole blood (EDTA), extracted DNA, or one drop of blood on FTA card | Typically whole blood only |
| Pre-test Genetic Counselling | Mandatory session with pedigree chart drawing included | Often optional, not integrated |
| Price | 2800 AED | Varies (2200–3200 AED) |
Physician Insight & Clinical Correlation
⚠️ Medication & Clinical Management Notice
Do not discontinue any prescribed medication, supplement, or prenatal vitamin without explicit instruction from your treating physician. This genetic test is for diagnostic purposes only and does not replace ongoing clinical monitoring or emergency care.
Exclusion Criteria & When to Seek Immediate Help
- Exclusion Criteria: Active, untreated severe coagulopathy (INR >1.8, platelets <50,000/μL) that contraindicates blood draw; inadequate sample volume or leakage on FTA card; inability to provide informed consent for testing.
- ER Red Flags (Call 998 immediately): Sudden severe shortness of breath or respiratory distress in the newborn/infant; suspected pathological fracture with limb deformity; signs of spinal cord compression (loss of limb movement, urinary retention).
- Non-urgent Medical Contact: For abnormal ultrasound findings suggestive of lethal skeletal dysplasia, contact your maternal‑fetal medicine specialist directly. Do not rely solely on genetic test results for acute management.
Patient FAQ & Clinical Guidance
ما هي دقة اختبار COL2A1 بتقنية NGS مقارنة بالفحص التقليدي؟
Snippet answer: NGS-based COL2A1 testing achieves over 99% diagnostic sensitivity for exonic and splice-site variants, significantly outperforming single-gene Sanger sequencing.
Our laboratory uses a clinically validated NGS pipeline with deep coverage, allowing detection of mosaic variants as low as 10% allele fraction and CNVs. Combined with expert variant interpretation following ACMG guidelines, this minimizes false negatives/positives and is the DHA-recommended first-tier genetic test for suspected Achondrogenesis type 2. A pre-test genetic counselling session is mandatory to interpret ancestry-specific variants and ensure clinical correlation with the pedigree chart.
كم يستغرق ظهور النتائج وهل يمكن تسريع العملية لحالات الطوارئ الطبية؟
Snippet answer: Standard turnaround time is 3–4 weeks, with a rush option delivering results in 10–12 business days for urgent prenatal decisions.
After sample accession, DNA extraction, NGS library preparation, sequencing, bioinformatics analysis, and clinical report drafting occur in our Dubai-based ISO-accredited facility. For time-sensitive cases (e.g., impending delivery or second-trimester ultrasound abnormalities), our medical team can expedite processing upon receiving a referral note from the attending physician. Please WhatsApp +971 54 548 8731 to request rush handling before sample collection.
هل تغطي شركات التأمين الصحي في الإمارات هذا الاختبار الجيني؟
Snippet answer: Many UAE insurers cover the COL2A1 NGS test when pre‑authorized with a genetic counselling referral, and we provide direct billing verification.
Since 2024, Federal Decree-Law No. 41 explicitly mandates coverage for medically necessary genetic tests under maternity and preventive care benefits, provided the ordering clinician registers the with DHA e-claim system. Our team liaises with insurers including Daman, AXA, Oman Insurance, and Nextcare to obtain approval within 24 hours—simply share your policy details via WhatsApp. Self-pay patients can also utilise our 0% instalment option.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians